9-FLUORO-11,21-DIHYDROXY-16,17-((1-METHYLETHYLIDENE)BIS(OXY))-2'-(4-PYRIDINYL)-2'H-PREGNA-2,4-DIENO(3,2-C)PYRAZOL-20-ONE, (11.BETA.,16.ALPHA.)-
UNII HY6TH5MPQ1
Substance Identification & Data
This profile provides standardized clinical and technical data for 9-fluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-2'-(4-pyridinyl)-2'h-pregna-2,4-dieno(3,2-c)pyrazol-20-one, (11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HY6TH5MPQ1.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 54999-15-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C30H36FN3O5 WTZVIDOKYWYFRG-PODHWHLESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9-fluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-2'-(4-pyridinyl)-2'h-pregna-2,4-dieno(3,2-c)pyrazol-20-one, (11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.